These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 1855324

  • 61. Chapter 10: Immunoglobulin A nephropathy.
    Kidney Int Suppl (2011); 2012 Jun; 2(2):209-217. PubMed ID: 25018935
    [No Abstract] [Full Text] [Related]

  • 62. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT, Lee GS.
    Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
    [No Abstract] [Full Text] [Related]

  • 63. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 64. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
    Brodsky SV, Rovin BH, Hebert LA.
    Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
    [No Abstract] [Full Text] [Related]

  • 65. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [Abstract] [Full Text] [Related]

  • 66. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
    Locatelli F, Vecchio LD, Pozzi C.
    Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
    [Abstract] [Full Text] [Related]

  • 67. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT, Lee GS.
    Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
    [No Abstract] [Full Text] [Related]

  • 68. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 69. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
    Brodsky SV, Rovin BH, Hebert LA.
    Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
    [No Abstract] [Full Text] [Related]

  • 70. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [Abstract] [Full Text] [Related]

  • 71. Follow-up renal biopsies in IgA nephritic patients on triple therapy.
    Woo KT, Chiang GS, Lim CH.
    Clin Nephrol; 1987 Dec; 28(6):304-5. PubMed ID: 3442958
    [No Abstract] [Full Text] [Related]

  • 72. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT, Lee GS.
    Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
    [No Abstract] [Full Text] [Related]

  • 73. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
    Locatelli F, Vecchio LD, Pozzi C.
    Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
    [Abstract] [Full Text] [Related]

  • 74. [Treatment of IgA nephropathy].
    Matousovic K, Mestecky J, Tomana M, Novak J.
    Vnitr Lek; 2008 Mar; 54(3):239-44. PubMed ID: 18522291
    [Abstract] [Full Text] [Related]

  • 75. [Treatment of childhood IgA nephropathy].
    Yoshikawa N.
    Nihon Jinzo Gakkai Shi; 2008 Mar; 50(4):468-72. PubMed ID: 18546876
    [No Abstract] [Full Text] [Related]

  • 76. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
    Woo KT, Lee GS.
    Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
    [No Abstract] [Full Text] [Related]

  • 77. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
    Locatelli F, Vecchio LD, Pozzi C.
    Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
    [Abstract] [Full Text] [Related]

  • 78. [Treatment of IgA nephropathy].
    Matousovic K, Mestecky J, Tomana M, Novak J.
    Vnitr Lek; 2008 Mar; 54(3):239-44. PubMed ID: 18522291
    [Abstract] [Full Text] [Related]

  • 79. [Treatment of childhood IgA nephropathy].
    Yoshikawa N.
    Nihon Jinzo Gakkai Shi; 2008 Mar; 50(4):468-72. PubMed ID: 18546876
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [New Search]
    of 4.